Connect to other sites within the UBM Medica Network
Deferring Postoperative RT for Pediatric Medulloblastoma Affected Survival
The deferral of postoperative radiotherapy is increasing among children with medulloblastoma, and this deferral of treatment was associated with worse survival.
Brain Function Differs By Medulloblastoma Subtype
Patients with different molecular subtypes of medulloblastoma, a common type of childhood brain tumor, have varying decline in brain function following radiation therapy for their disease.
Insurance Status Affected Glioblastoma Survival
Patients with glioblastoma who were uninsured or who had Medicaid at the time of diagnosis were more likely to be diagnosed with a larger tumor and had shorter survival times.
Gene Underexpression Linked With Poor Glioblastoma Prognosis
The underexpression of one of the homeobox (HOX) genes, HOXA11, is associated with poor prognosis in patients with glioblastoma.
Radiosurgery and Immunotherapy for Melanoma Patients With Brain Metastases
In this video we discuss the use of concurrent immunotherapy and stereotactic radiosurgery for treatment of melanoma brain metastases.
Concurrent SRS, Immunotherapy Improved Response in Melanoma Brain Mets
Undergoing immunotherapy within a month of stereotactic radiosurgery resulted in an improved response to treatment for patients with melanoma brain metastases.
Adjuvant Temozolomide Improves Survival in Some Anaplastic Gliomas Patients
Adjuvant temozolomide chemotherapy following radiotherapy improves survival among patients with anaplastic gliomas that do not harbor 1p/19q co-deletions, according to interim results from a phase III trial.
ASCO: No Benefit From Avastin in Newly Diagnosed Glioblastoma
Results of two phase III trials, presented at ASCO, on the addition of bevacizumab (Avastin) to standard therapy in newly diagnosed glioblastoma found that the drug added no benefit.
By clicking Accept, you agree to become a member of the UBM Medica Community.